Holen Sie sich die Stockscreener-App
10.97
4.86%
-0.56
Handel nachbörslich:
10.98
0.010
+0.09%
Schlusskurs vom Vortag:
$11.53
Offen:
$11.62
24-Stunden-Volumen:
43,825
Relative Volume:
0.84
Marktkapitalisierung:
$149.52M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.89M
KGV:
-15.67
EPS:
-0.7
Netto-Cashflow:
$-6.48M
1W Leistung:
-4.28%
1M Leistung:
-8.12%
6M Leistung:
-8.20%
1J Leistung:
-18.32%
1-Tages-Spanne:
$10.87
$11.68
1-Wochen-Bereich:
$10.87
$11.91
52-Wochen-Spanne:
$8.06
$16.50
Greenwich Lifesciences Inc Stock (GLSI) Company Profile
Firmenname
Greenwich Lifesciences Inc
Sektor
Branche
Telefon
203-434-3290
Adresse
3992 BLUEBONNET DR, BUILDING 14, STAFFORD
Vergleichen Sie GLSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLSI
Greenwich Lifesciences Inc
|
10.97 | 156.20M | 0 | -8.89M | -6.48M | -0.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Greenwich Lifesciences Inc Stock (GLSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-20 | Eingeleitet | Noble Capital Markets | Outperform |
| 2021-09-01 | Eingeleitet | H.C. Wainwright | Buy |
Greenwich Lifesciences Inc Aktie (GLSI) Neueste Nachrichten
Is Greenwich LifeSciences Inc. stock bottoming outJuly 2025 Chart Watch & Free Weekly Chart Analysis and Trade Guides - Newser
Real time pattern detection on Greenwich LifeSciences Inc. stock2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
How sentiment analysis helps forecast Greenwich LifeSciences Inc.July 2025 Intraday Action & AI Forecasted Entry/Exit Points - Newser
Is Greenwich LifeSciences Inc. stock reversal real or fakeVolume Spike & Free Daily Entry Point Trade Alerts - Newser
Relative strength of Greenwich LifeSciences Inc. in sector analysis2025 Breakouts & Breakdowns & Weekly Breakout Opportunity Watchlist - Newser
Using economic indicators to assess Greenwich LifeSciences Inc. potentialInsider Selling & Free Daily Entry Point Trade Alerts - Newser
Automated trading signals detected on Greenwich LifeSciences Inc.2025 Stock Rankings & Free AI Powered Buy and Sell Recommendations - Newser
Short interest data insights for Greenwich LifeSciences Inc.2025 Big Picture & Growth Oriented Trade Recommendations - Newser
What Fibonacci levels say about Greenwich LifeSciences Inc. rebound2025 Big Picture & Verified Entry Point Signals - Newser
What to expect from Greenwich LifeSciences Inc. in the next 30 daysPortfolio Value Report & Real-Time Market Trend Scan - Newser
Leading vs lagging indicators on Greenwich LifeSciences Inc. performanceAnalyst Downgrade & Fast Entry and Exit Trade Plans - Newser
Can Greenwich LifeSciences Inc. reach all time highs this yearMarket Sentiment Review & Low Drawdown Trading Techniques - khodrobank.com
Is Greenwich LifeSciences Inc. stock overvalued or fairly priced2025 Bull vs Bear & High Accuracy Investment Signals - khodrobank.com
Tools to assess Greenwich LifeSciences Inc.’s risk profileQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - Newser
Can trapped investors hope for a rebound in Greenwich LifeSciences Inc.July 2025 Rallies & Safe Capital Allocation Plans - Newser
Technical analysis overview for Greenwich LifeSciences Inc. stockLayoff News & Safe Entry Zone Tips - Newser
Will Greenwich LifeSciences Inc. outperform the marketJuly 2025 Final Week & Daily Profit Focused Stock Screening - Newser
Advanced analytics toolkit walkthrough for Greenwich LifeSciences Inc.2025 Price Action Summary & Verified Momentum Stock Ideas - Newser
Greenwich LifeSciences Inc. stock volume spike explained2025 Price Momentum & Verified Trade Idea Suggestions - Newser
Comparing Greenwich LifeSciences Inc. in custom built stock radarsWeekly Market Report & Capital Efficiency Focused Ideas - Newser
Is Greenwich LifeSciences Inc. a defensive stock2025 Short Interest & Free Long-Term Investment Growth Plans - khodrobank.com
Has Greenwich LifeSciences Inc. found a price floorWeekly Trend Report & Long-Term Growth Stock Strategies - Newser
Price momentum metrics for Greenwich LifeSciences Inc. explained2025 Risk Factors & Free Long-Term Investment Growth Plans - Newser
Is it time to cut losses on Greenwich LifeSciences Inc.Portfolio Return Report & Smart Money Movement Alerts - Newser
Short Interest Drops in Greenwich LifeSciences Inc. After RallyMarket Trend Review & High Accuracy Investment Signals - beatles.ru
Greenwich LifeSciences initiated with an Outperform at Noble Capital - MSN
AI Tools Suggest Greenwich LifeSciences Inc. May Outperform This Week getLinesFromResByArray error: size == 0 - newsyoung.net
Quantitative breakdown of Greenwich LifeSciences Inc. recent moveAnalyst Upgrade & Expert Curated Trade Setups - Newser
How to read the order book for Greenwich LifeSciences Inc.Weekly Earnings Recap & Low Drawdown Investment Strategies - Newser
What makes Greenwich LifeSciences Inc. stock price move sharplyPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Chart overlay techniques for tracking Greenwich LifeSciences Inc.Market Weekly Review & Weekly High Conviction Ideas - Newser
Published on: 2025-08-30 21:48:06 - Newser
Finanzdaten der Greenwich Lifesciences Inc-Aktie (GLSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Greenwich Lifesciences Inc-Aktie (GLSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Patel Snehal | CEO and CFO |
Apr 17 '25 |
Buy |
8.98 |
5,400 |
48,492 |
5,567,002 |
| Patel Snehal | CEO and CFO |
Apr 07 '25 |
Buy |
9.10 |
3,600 |
32,760 |
5,561,602 |
| Patel Snehal | CEO and CFO |
Apr 04 '25 |
Buy |
8.73 |
5,500 |
48,015 |
5,558,002 |
| Patel Snehal | CEO and CFO |
Jan 10 '25 |
Buy |
12.51 |
2,500 |
31,275 |
5,552,502 |
| Patel Snehal | CEO and CFO |
Jan 07 '25 |
Buy |
13.75 |
1,800 |
24,750 |
5,550,002 |
| Patel Snehal | CEO and CFO |
Jan 06 '25 |
Buy |
13.31 |
1,100 |
14,641 |
5,548,202 |
| Patel Snehal | CEO and CFO |
Jan 03 '25 |
Buy |
12.95 |
3,400 |
44,030 |
5,547,102 |
| Patel Snehal | CEO and CFO |
Jan 02 '25 |
Buy |
11.97 |
2,000 |
23,940 |
5,543,702 |
| Patel Snehal | CEO and CFO |
Dec 31 '24 |
Buy |
11.36 |
2,400 |
27,264 |
5,541,702 |
| Patel Snehal | CEO and CFO |
Dec 30 '24 |
Buy |
11.12 |
3,200 |
35,584 |
5,539,302 |
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):